87 related articles for article (PubMed ID: 20797840)
1. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):801-9. PubMed ID: 20797840
[TBL] [Abstract][Full Text] [Related]
2. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):481-9. PubMed ID: 17467249
[TBL] [Abstract][Full Text] [Related]
3. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
4. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia.
Tyldesley S; Delaney G; Foroudi F; Barbera L; Kerba M; Mackillop W
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1507-15. PubMed ID: 20605338
[TBL] [Abstract][Full Text] [Related]
5. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
6. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer.
Tyldesley S; McGahan C
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):526-32. PubMed ID: 20594811
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
8. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies.
Delaney G; Jacob S; Barton M
Cancer; 2005 Feb; 103(3):462-73. PubMed ID: 15612081
[TBL] [Abstract][Full Text] [Related]
9. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in ontario.
Mackillop WJ; Kong W; Brundage M; Hanna TP; Zhang-Salomons J; McLaughlin PY; Tyldesley S
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1099-107. PubMed ID: 25832700
[TBL] [Abstract][Full Text] [Related]
10. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
11. Testing criterion-based benchmarking for the appropriate use of radiotherapy.
Barton MB; Gabriel GS; Delaney GP
Radiother Oncol; 2018 Sep; 128(3):406-410. PubMed ID: 29880221
[TBL] [Abstract][Full Text] [Related]
12. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
13. Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care.
Jacob S; Ng W; Asghari R; Delaney GP; Barton MB
Eur J Cancer; 2009 Sep; 45(14):2503-9. PubMed ID: 19527926
[TBL] [Abstract][Full Text] [Related]
14. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
[TBL] [Abstract][Full Text] [Related]
15. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
Wesley D; Cox HF
J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
[TBL] [Abstract][Full Text] [Related]
16. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
Abdel-Wahab M; Reis IM; Hamilton K
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
[TBL] [Abstract][Full Text] [Related]
18. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care.
Ng W; Delaney GP; Jacob S; Barton MB
Eur J Cancer; 2010 Mar; 46(4):703-12. PubMed ID: 20034784
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic factors associated with postprostatectomy radiotherapy.
Krupski TL; Kwan L; Litwin MS
Prostate Cancer Prostatic Dis; 2005; 8(2):184-8. PubMed ID: 15809671
[TBL] [Abstract][Full Text] [Related]
20. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
Alibhai SM; Leach M; Warde P
Cancer; 2009 Jan; 115(2):293-302. PubMed ID: 19025976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
